smedo develops a contactless medical system that continuously measures cardiac vital signs such as heartbeat and breathing using high-resolution signal processing of radar signals reflected from the skin. The system requires no body-worn sensors and is intended for deployment in hospitals, nursing homes and the home environment, with potential applications including baby monitoring. The company is pursuing diagnostic approaches aimed at early detection of fatal cardiac events such as heart attacks. smedo closed a €1.66m seed financing round to advance development and the market launch of its system. The round was funded by APEX Ventures in cooperation with Brandenburg Kapital. smedo was founded by Thomas Grellner, has been operational since 2021, and is based in Hennigsdorf.

Total raised

$2M

Funding rounds

1

Latest round

Seed

Latest activity

Apr 2022